MIRENA® (52mg levonorgestrel) contraceptive use extended to eight years
An important change to the label of one of the most effective methods of contraception will see thousands of women protected from unintended pregnancy for…
See all the press release content from the industry
An important change to the label of one of the most effective methods of contraception will see thousands of women protected from unintended pregnancy for…
Your work is key to helping Australia continue to enjoy high rates of childhood immunisation. But not every parent feels ready to vaccinate. Listening is…
Tafamidis (Vyndamax) – a once-daily oral treatment – was added to the Pharmaceutical Benefits Scheme (PBS) on 1 May 2024. This marks the first and…
Prevenar 20® is now TGA approved for infants and children from 6 weeks of age1 In Australia, we’ve trusted Prevenar to help protect us against…
In an ever-evolving healthcare landscape, medical professionals are embracing innovative solutions to enhance patient care and streamline their operations. 2023 has seen a significant shift…
The Content is produced and promoted by Astellas Pharma Enfortumab vedotin is now available for eligible patients who received prior platinum-containing chemotherapy and a PD-1/L1…
Alcohol Use Disorder (AUD) remains the mental health diagnosis with the lowest treatment ratesi, a concerning reality given its rising incidence In Australia post COVID.…
LET’S UNITE FOR INTERNATIONAL OVERDOSE AWARENESS DAY 2023, AS WE REMEMBER LIVES LOST, CHALLENGE STIGMA, AND WORK TOGETHER FOR A SAFER, MORE COMPASSIONATE COMMUNITY On…
Do you want to know more about Voluntary Assisted Dying (VAD)? Join other clinicians and VAD experts at the national VAD Conference in Sydney in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.